Summary
- Pfizer
secured a 3-year tariff grace period from the Trump administration. - The
deal requires US manufacturing investment by Pfizer. - Pfizer
agrees to cut US drug prices by up to 50%.
In an effort to enable Americans to pay for prescription
drugs at government-negotiated reduced prices, Pfizer will provide a number of
medications at an average 50% discount via a direct-to-consumer website named
TrumpRx.
The agreement seems to address Pfizer’s two main challenges.
In addition to protecting the business from potential tariffs imposed by the
administration’s Section 232 investigation into whether the cost of medications
poses a national security danger, it would prevent more harmful drug pricing
measures.
Trump has unilaterally used trade policy to gain control
over numerous businesses, and this is the most recent illustration of the
transactional nature of obtaining tariff exemptions from him. Trump threatened
to impose 100% tariffs on the pharmaceutical industry as recently as last week.
Following the announcement of the tariff relief, Pfizer’s
stock increased by as much as 5.6%, reaching a session high. As of Monday’s
close, the stock had lost 10% of its value this year, lagging behind the 13%
increase in the S&P 500 Index.
There may be more discounts to come.
As authorities negotiate with large pharmaceutical
companies, Commerce Secretary Howard Lutnick hinted that the administration was
delaying the findings of its national security investigation of pharmaceutical
imports that would lead
to higher tariffs.
“While we’re negotiating with these companies we’re going to
let them play out and finish these negotiations,”
Lutnick said.
Trump previously said that his administration would impose
100% duties on branded pharmaceuticals starting Wednesday unless a company was
building US manufacturing plants. The latest comments from the president and
his advisers indicate that the threat was a negotiating ploy to get companies
to lower prices on their products.
“They’re all coming in over the next week. We’re making
deals with all of them. And I said if we don’t make a deal, then we’re going to
tariff them an extra, 5, 6, 7, 8%. Whatever the difference is, we’ll take that
away,”
Trump said.
Pfizer said it will offer across-the-board reductions on US
prices for Americans enrolled in the Medicaid insurance program, giving them
“most favored nation” pricing on some of its medicines, Trump said. He has
repeatedly pressured companies to bring their US prices in line with what
foreign countries pay.
Bourla also declared a $70 billion investment in domestic
manufacturing and research and development during the ensuing years. In
response to pressure from Trump, the corporation was one of the few outliers
among large pharmaceutical companies that hurried to emphasize the return of
production plants to the United States.
Pfizer stated that the majority of its primary care
medications would be available on TrumpRx, although it did not identify which
of its medications would be made available there. Pfizer’s best-selling
medications include the Covid injection and pill, the pneumonia vaccination
Prevnar, and the blood thinner Eliquis.
By using their personal connections with the president, big
businesses and influential executives have been able to influence him to grant
them better terms.
“While Democrats are threatening to shut down the government
to subsidize health care for illegal aliens, President Trump is leveraging the
power of the federal government to drastically cut drug prices for everyday
Americans,”
White House spokesman Kush Desai said in a statement.
“Democrats
talked the talk for decades about drug prices, but only President Trump is
actually walking the walk.”
Companies must lower Medicaid costs, raise their drug
pricing abroad, pledge to match international prices for future products to US
rates, and provide reduced direct-to-consumer sales for some commonly used
prescriptions, according to the most-favored-nation policy.
In July, Trump sent letters outlining his requests to 17 of
the biggest pharmaceutical companies in the world, including Pfizer, Novo
Nordisk A/S, and Eli Lilly & Co. The president promised to “deploy
every tool in our arsenal” to penalize drug manufacturers that failed to
comply, and the firms were given until September 29 to comply.
The idea of internationally linked drug prices has been
criticized by the pharmaceutical industry as a danger to the United States’
long-standing hegemony in biomedical research. Manufacturers of pharmaceuticals
argue that it will discourage the development of innovative treatments and keep
patients from receiving necessary medications. Instead, executives have asked
the administration to focus on the middlemen that negotiate costs for employers
in the pharmaceutical supply chain.
Which Pfizer drugs are slated for the TrumpRx discounts?
The medications from Pfizer that are eligible for discounts
through the TrumpRx program will include most of Pfizer’s major care
medications and a small sample of specialty brand-name drugs. The average
discount on these medications offered through TrumpRX will be approximately 50%
with some discounts as high as 85%.
This price reduction will take effect shortly, as Pfizer
operates a direct-to-consumer website for the TrumpRX program to allow
Americans to buy these medications at a much lower cost.
In addition, Pfizer will also offer “most favored nation”
pricing on drugs that are covered by Medicaid, which ensures U.S. prices will
be aligned with the lowest price paid in other developed countries, as part of
an action agreement with the Trump administration to reduce prescription drug
costs.
